BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Expands Roswell Facility to Increase Manufacturing Capacity

Stock price chart of Zomedica Corp. (EBR:ZOM) showing fluctuations.

Zomedica Corp. (NYSE American:ZOM), a veterinary health company, has completed the expansion of its manufacturing and distribution facilities in Roswell, Georgia. This expansion increases the facility size to 18,400 sq. ft., adding 6,000 sq. ft., and enhancing warehouse and sales order fulfillment efficiencies. The increased capacity supports the growing demand for Zomedica's products.

Tony Blair, Executive Vice President and COO, notes that the additional warehousing and order fulfillment capacity will improve efficiencies. The Roswell facility is managed by a team with extensive operational experience, ensuring the capacity increase and streamlined distribution for current and future products.

Zomedica's Roswell facility manufactures key products including TRUVIEWTM, VetGuardian®, Assisi®, PulseVet®, and TRUFORMA® instruments. TRUFORMA® cartridges are produced at the Plymouth, Minnesota facility. CEO Larry Heaton is pleased with the progress at Roswell, stating that the expansion aligns with the company's rapid sales growth and commitment to meeting customer demand.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news